In particular, we demonstrated that cells and tumors that express p140Cap show increased synthesis of the MVA products by the upregulation of the rate-limiting enzyme of the MVA pathway, HMGCR, therefore affecting tumor cell properties such as cell migration and sensitivity to drug treatments, upon combinatory treatments with low dose statins and conventional chemotherapeutic drugs (Fig. 7). This evidence concerns the gene HMGCR and neoplasm.